Answers are grounded in this paper and cite their sources.
Clinical review demonstrates extended survival with riluzole in ALS patients, highlighting modest therapeutic benefit.
Riluzole 100 mg daily is reasonably safe and probably prolongs survival by about two months in patients with ALS. More studies are needed, especially to clarify its effect in older patients (over 75 years), and those with more advanced disease.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: